In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cells

European Journal of Cancer Part A

Volumn 32, Issue 8, 1996, Pages 1420-1428

  Lee, Y N ^a   Lee, H Y ^a   Chung, H Y ^a   Kim, S I ^b   Lee, S K ^c   Park, B C ^d   Kim, K W ^a  

^a Pusan National University   (South Korea)

^b Korea Ginseng Corporation   (South Korea)

^c Seoul National University   (South Korea)

^d Kosin University   (South Korea)

Author keywords

Differentiation; F9 teratocarcinoma cells; Ginsenosides

Indexed keywords

BUCLADESINE; GINSENOSIDE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; MIFEPRISTONE; THEOPHYLLINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING; TERATOCARCINOMA;

EID: 0030017733     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00102-5     Document Type: Article

References (39)

1. Pierce GB, Podesta A, Wells RS. Malignancy and differentiation: the role of the blastocyst in control colony formation. CSH Conf Cell Proliferation 1983, 10, 15-22.
2. Verma IM, Corsi PS. Proto-oncogene fos: complex but versatile regulation. Cell 1987, 51, 513-514.
3. Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. Cancer Res 1983, 43, 3034-3040.
4. Strickland S, Sawey MJ. Studies on the effect of retinoids on the differentiation of teratocarcinoma cells in vitro and in vivo. Dev Biol 1980, 78, 76-85.
5. Strickland S, Smith KK, Marotti KR. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cyclic AMP. Cell 1980, 21, 347-355.
6. Martin GR. Teratocarcinomas and mammalian embryogenesis. Science 1989, 209, 768-776.
7. Wang SY, LaRosa GJ, Gudas LJ. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells. Dev Biol 1985, 107, 75-86.
8. Griep AE, Deluca HF. Studies on the relation of DNA synthesis to retinoic acid induced differentiation of F9 teratocarcinoma cells. Exp Cell Res 1986, 164, 223-231.
9. Eriksson U, Hansson E, Jonsson KH, Sundelin J, Peterson E. Increased level of several retinoid binding proteins resulting from retinoic acid-induced differentiation of F9 cells. Cancer Res 1986, 46, 712-722.
10. Hosler BA, LaRosa GJ, Grippo JF, Gudas LJ. Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol Cell Biol 1989, 9, 5623-5629.
11. Yamamoto H, Katano M, Matsunaga H. Anti-tumor substance from panax ginseng roots. Korean J Ginseng Sci 1990, 14, 244-252.
12. Ota T, Fujikawa-Yamamoto K, Zong ZP, Yamazaki M, Odashima S. Plant-glycoside modulation of cell surface related to control of differentiation in cultured B16 melanoma cells. Cancer Res 1987, 47, 3863-3867.
13. 2 by cultured B16 melanoma cells. J Pharmaceut Sci 1991, 80, 1141-1146.
14. Odashima S, Ota T, Kohno H, et al. Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res 1985, 45, 2781-2784.
15. Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Taniyama T. Chemical studies on crude drug precession I. On the constituents of Ginseng Radix Rubra(1). Yakugaku Zasshi 1983, 103, 612-622.
16. Feinberg AP, Vogelstein BA. Technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984, 137, 255-267.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162, 156-159.
18. Silva CM, Tully DB, Petch LA, Jewell CM, Ciduiwski JA. Amplication of a protein-blotting procedure to the study of human glucocorticoid receptor interactions with DNA. Proc Natl Acad Sci USA 1987, 84, 1744-1748.
19. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 1976, 72, 248-254.
20. Dignam JD, Lebowitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983, 11, 1475-1489.
21. Sambrook J, Fritsch EF, Maniatis T. Introduction of recombinant vectors into mammalian cells. Molecular Cloning, A Laboratory Manual, 2nd edn. New York, Cold Spring Harbor, 1989, 16.30-16.40.
22. Northrop JP, Gametchu B, Harrison RW, Ringold GM. Characterization of wild type and mutant glucocorticoid receptors from rat hepatoma and mouse lymphoma cells. J Biol Chem 1985, 260, 6398-6403.
23. Schule R, Muller M, Otsuka-Murakami H, Renkawitz R. Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature 1988, 332, 87-90.
24. Marotti KR, Brown GD, Strickland S. Two-stage hormonal control of type IV collagen mRNA levels during differentiation of F9 teratocarcinoma cells. Dev Biol 1985, 108, 26-31.
25. Lotan R, Lotan D. Stimulation of melanogenesis in a human melanoma cell line by retinoids. Cancer Res 1980, 40, 3345-3350.
26. Prasad KN, Edaward-Prasad J. Effects of tocopherol (Vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. Cancer Res 1982, 42, 550-555.
27. Yun TK, Choi SY. A case-control study of ginseng intake and cancer. Int J Epidemiol 1990, 19, 871-876.
28. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prevention 1995, 4, 401-408.
29. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988, 240, 889-895.
30. Beato M. Gene regulation by steroid hormones. Cell 1989, 56, 335-344.
31. Wright APH, Carlstedt-Duke J, Gustafsson J-Å. Ligand-specific transactivation of gene expression by a derivative of the human glucocorticoid receptor expressed in yeast. J Biol Chem 1990, 265, 14763-14769.
32. Zilliacus J, Wright APH, Norinder U, Gustafsson J-Å, Carlstedt-Duke J. Determinants for DNA-binding site recognition by the glucocorticoid receptor. J Biol Chem 1992, 267, 24941-24947.
33. Scheidereit C, Gisse S, Westphal HM, Beato M. The glucocorticoid receptor binds to defined nucleotide sequences near the promotor of mouse mammary tumor. Nature 1983, 304, 749-752.
34. Philibert D. RU38486: an original multifaceted antihormone in vivo. In Agarwal MK, ed. Adrenal Steroid Antagonism, de Gruyter, Berlin, 1984, 77-101.
35. Baulieu E-E. Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science 1989, 245, 1351-1357.
36. Horwotz KB. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 1992, 13, 146-163.
37. Mao J, Regelson W, Kalimi M. Molecular mechanism of RU486 action: a review. Mol Cell Biochem 1992, 109, 1-8.
38. Gronemeyer H, Meyer M-E, Bocquel M-T, Kastner P, Turcotte B, Chambon P. Progestin receptors: isoforms and antihormone action. J Steroid Biochem 1991, 40, 271-278.
39. 1 on tyrosine aminotransferase gene expression in rat primary hepatocyte cultures. Biochem Mol Biol Int 1994, 34, 845-851.